Literature DB >> 1689229

Effects of alcohol and nicotine on cytotoxic functions of human lymphocytes.

M P Nair1, Z A Kronfol, S A Schwartz.   

Abstract

The in vitro effects of the recreational drugs, ethanol (EtOH) and nicotine, on natural killer (NK) antibody-dependent cellular cytotoxic (ADCC) and lymphokine-activated killer (LAK) cell activities on normal lymphocytes were investigated. Lymphocytes precultured with EtOH at concentrations of 0.4 and 0.6% (v/v) produced significant suppression of NK and ADCC activities. In target-binding assays, EtOH decreased the target-binding capacity of effector cells. EtOH also inhibited the activities of Percoll-separated, NK-enriched large granular lymphocytes. EtOH-induced inhibition of NK activity could be reversed by incubating lymphocytes for 1 hr with interferon. The generation and lytic capacity of LAK cells was also significantly depressed by EtOH when added at the initiation of culture. Nicotine at concentrations of 5 and 10 micrograms/ml, when added directly to mixtures of effector and target cells, produced significant inhibition of NK activity. Nicotine (2 micrograms/ml) and EtOH (0.01, 0.1, and 0.2%) at noninhibitory concentrations when added separately, showed significant suppression of NK activity when used in combination. Pretreatment of target cells with either EtOH or nicotine for 4 hr did not affect cytotoxic activity. Inhibition of cytotoxicity was also not due to direct toxicity of effector cells because lymphocytes treated with either EtOH or nicotine showed normal 51Cr release and their viability was comparable to that of untreated control cells. These studies demonstrate that EtOH and nicotine have significant immunomodulatory effects on the cytotoxic activities of human lymphocytes which may be of clinical relevance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689229     DOI: 10.1016/0090-1229(90)90053-s

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  8 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 2.  Cigarette smoking and intestinal defences.

Authors:  G F Cope; R V Heatley
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

3.  Considerations regarding use of solvents in in vitro cell based assays.

Authors:  Michael Timm; Lasse Saaby; Lise Moesby; Erik Wind Hansen
Journal:  Cytotechnology       Date:  2013-01-18       Impact factor: 2.058

4.  Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women.

Authors:  Eva A Operskalski; Wendy J Mack; Howard D Strickler; Audrey L French; Michael Augenbraun; Phyllis C Tien; Maria C Villacres; LaShonda Y Spencer; Marina Degiacomo; Andrea Kovacs
Journal:  J Clin Virol       Date:  2008-02-20       Impact factor: 3.168

5.  Ethanol affects fibroblast behavior differentially at low and high doses: A comprehensive, dose-response evaluation.

Authors:  Neelakshi Kar; Deepak Gupta; Jayesh Bellare
Journal:  Toxicol Rep       Date:  2021-05-18

6.  Association Between Alcohol Use Disorders and Outcomes of Patients Hospitalized With Community-Acquired Pneumonia.

Authors:  Niyati M Gupta; Peter K Lindenauer; Pei-Chun Yu; Peter B Imrey; Sarah Haessler; Abhishek Deshpande; Thomas L Higgins; Michael B Rothberg
Journal:  JAMA Netw Open       Date:  2019-06-05

7.  Respiratory health effects of residential individual and cumulative risk factors in children living in two cities of the Pearl River Delta Region, China.

Authors:  Jianqing Lin; Weiwei Lin; Zixuan Yin; Xi Fu; Dejian Mai; Shaojie Fu; Junfeng Jim Zhang; Jicheng Gong; Ning Feng; Lingyan He
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 3.005

8.  Substance use (alcohol, areca nut and cigarette) is associated with poor prognosis of esophageal squamous cell carcinoma.

Authors:  I-Chen Wu; Chun-Chieh Wu; Chien-Yu Lu; Wen-Hung Hsu; Meng-Chieh Wu; Jui-Ying Lee; Shah-Hwa Chou; Jang-Ming Lee; Yi-Ping Chou; Deng-Chyang Wu; Ming-Tsang Wu
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.